Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound (HIFU). A Prospective, Multicenter, Open-label, Safety and Efficacy Study of the Treatment With the EYEOP Medical Device in Patients With Refractory Glaucoma

No previous intraocular glaucoma surgery or laser treatment in the study eye during the 3 months before HIFU treatment

No previous cyclophotocoagulation procedure in the study eye

Patient able and willing to provide informed consent and to complete post-operative follow-up requirements.

Exclusion Criteria:

History of previous glaucoma surgery with implantation of glaucoma drainage device in the study eye

History of ocular or retrobulbar tumor

Retinal detachment, choroidal hemorrhage or detachment

Ocular infectious disease within 14 days before HIFU treatment

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01338467